The firm has extensive experience working with organisations across the industry, including: proprietary and generic drug manufacturers, specialty drug makers, medical device and diagnostics suppliers, biotechnology companies, wholesalers, pharmacy benefit managers, contract research organisations, and industry associations. It has made a deep commitment to understanding the forces affecting clients' operations and has aligned its practice with the market to ensure that its people are deeply knowledgeable about the relationships that suppliers have with providers, payers, regulators and patients.
PricewaterhouseCoopers provides industry-focused assurance, tax and advisory services to build public trust and enhance value for its clients and their stakeholders. More than 146,000 people in 150 countries across its network share their thinking, experience and solutions to develop fresh perspectives and practical advice.
PricewaterhouseCoopers is the leading professional services organisation in mainland China, Hong Kong and Macau, with a total staffs strength of 9,000, including close to 330 partners. Its offices in mainland China comprise: Beijing, Chongqing, Dalian, Guangzhou, Qingdao, Shanghai, Shenzhen, Suzhou, Tianjin and Xi'an.
"PricewaterhouseCoopers" refers to the network of member firms of PricewaterhouseCoopers International Limited, each of which is a separate and independent legal entity.